232 related articles for article (PubMed ID: 30213435)
1. A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice.
Jazaeri A; Coleman RL; Sood AK; Frumovitz MM; Soliman PT; Shafer A; Cutrera JJ; Klinger M; Sharafi SE; Johnson CAL; Villanueva VF; Hinchcliff EM; Dickens A; Cain KE; Anderson JE; Lu KH; Westin SN
Gynecol Oncol; 2018 Nov; 151(2):374-380. PubMed ID: 30213435
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in Gynecologic Cancers: Are We There Yet?
Pakish JB; Jazaeri AA
Curr Treat Options Oncol; 2017 Aug; 18(10):59. PubMed ID: 28840453
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Gynecologic Cancers: What We Know Now and Where We Are Headed.
Levinson K; Dorigo O; Rubin K; Moore K
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e126-e140. PubMed ID: 31099679
[TBL] [Abstract][Full Text] [Related]
4. Immuno-oncology for Gynecologic Malignancies.
How J; Patel A; Jazaeri A
Adv Exp Med Biol; 2020; 1244():149-182. PubMed ID: 32301014
[TBL] [Abstract][Full Text] [Related]
5. Cell-based immunotherapy in gynecologic malignancies.
Schaar B; Krishnan V; Tallapragada S; Dorigo O
Curr Opin Obstet Gynecol; 2018 Feb; 30(1):23-30. PubMed ID: 29227304
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers.
Menderes G; Hicks C; Black JD; Schwab CL; Santin AD
Expert Opin Biol Ther; 2016 Aug; 16(8):989-1004. PubMed ID: 27070175
[TBL] [Abstract][Full Text] [Related]
7. An Overview of Immune Checkpoint Inhibitors in Gynecologic Cancers.
Castellano T; Moore KN; Holman LL
Clin Ther; 2018 Mar; 40(3):372-388. PubMed ID: 29530456
[TBL] [Abstract][Full Text] [Related]
8. Women's cancer: Advancing molecular and immunotherapy.
Dorigo O
Curr Probl Cancer; 2017; 41(1):7. PubMed ID: 28366203
[No Abstract] [Full Text] [Related]
9. Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine.
Zamarin D; Jazaeri AA
Gynecol Oncol; 2016 Apr; 141(1):86-94. PubMed ID: 27016233
[TBL] [Abstract][Full Text] [Related]
10. T-cell target antigens across major gynecologic cancers.
Rodriguez-Garcia A; Minutolo NG; Robinson JM; Powell DJ
Gynecol Oncol; 2017 Jun; 145(3):426-435. PubMed ID: 28377094
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy: Checkpoint Inhibitors in Lynch-Associated Gynecologic Cancers.
Ferriss JS; Williams-Brown MY
Curr Treat Options Oncol; 2019 Aug; 20(10):75. PubMed ID: 31444655
[TBL] [Abstract][Full Text] [Related]
12. Immuno-Oncology for Gynecologic Malignancies.
How JA; Patel A; Jazaeri AA
Adv Exp Med Biol; 2021; 1342():193-232. PubMed ID: 34972966
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Lee L; Matulonis U
Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
[TBL] [Abstract][Full Text] [Related]
14. Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers.
Liu YL; Zamarin D
Curr Oncol Rep; 2018 Nov; 20(12):94. PubMed ID: 30421009
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
Blair AB; Murphy A
Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
[TBL] [Abstract][Full Text] [Related]
16. [Practical value of immunotherapy in gynecologic oncology].
Mallmann P
Zentralbl Gynakol; 1999; 121(4):183-4. PubMed ID: 10355094
[No Abstract] [Full Text] [Related]
17. Immunotherapy: New Strategies for the Treatment of Gynecologic Malignancies.
Bourla AB; Zamarin D
Oncology (Williston Park); 2016 Jan; 30(1):59-66, 69. PubMed ID: 26791846
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for gynecologic cancers.
Liao JB
Gynecol Oncol; 2016 Jul; 142(1):3-5. PubMed ID: 27242186
[No Abstract] [Full Text] [Related]
19. [Immunotherapy in gynecologic oncology].
Krebs D
Zentralbl Gynakol; 1996; 118(10):578. PubMed ID: 8999715
[No Abstract] [Full Text] [Related]
20. Cell-based immunotherapy in gynecologic malignancies.
Schaar B; Krishnan V; Tallapragada S; Chanana A; Dorigo O
Curr Opin Obstet Gynecol; 2019 Feb; 31(1):43-48. PubMed ID: 30540582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]